Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

Primacann

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
7
Portfolio
2 Strains
Mentions (90d)
12
Brand Score (90d)
73
vs Market Avg: 63 vs All Time: 68
Performing Well

Rating higher than the 90d community baseline.

Medication Portfolio (2)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
151
20.0% Yes
8
63
65
402
28.0%
4
93
93